WHO's rollout of malaria vaccine in Africa: can safety questions be answered after only 24 months?

BMJ. 2020 Jan 24;368:l6920. doi: 10.1136/bmj.l6920.

Peter Aaby^{1

2}, Ane B Fisker^{1

2

3}, Anders Björkman⁴, Christine Stabell Benn^{5

2

3

6}

¹ Bandim Health Project, INDEPTH Network, Apartado 861, Bissau, Guinea-Bissau.
² Research Centre for Vitamins and Vaccines (CVIVA), Bandim Health Project, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark.
³ OPEN, Odense Patient data Explorative Network, Institute of Clinical Research, Odense University Hospital/ University of Southern Denmark.
⁴ Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
⁵ Bandim Health Project, INDEPTH Network, Apartado 861, Bissau, Guinea-Bissau cbenn@health.sdu.dk.
⁶ Danish Institute of Advanced Science, University of Southern Denmark.

No abstract available

MeSH terms